DNA repair pathways and mitochondrial DNA mutations in gastrointestinal carcinogenesis

被引:49
作者
Basso, Daniela
Navaglia, Filippo
Fogar, Paola
Zambon, Carlo-Federico
Greco, Eliana
Schiavon, Stefania
Fasolo, Michela
Stranges, Alessia
Falda, Alessandra
Padoan, Andrea
Fadi, Elisa
Pedrazzoli, Sergio
Plebani, Mario
机构
[1] Univ Hosp Padova, Dept Lab Med, I-35128 Padua, Italy
[2] Univ Padua, Dept Med & Surg Sci, I-35100 Padua, Italy
[3] Veneto Oncol Inst, Padua, Italy
关键词
pancreatic cancer; mitochondrial DNA; gene polymorphisms; DNA repair pathways; gastrointestinal carcinogenesis;
D O I
10.1016/j.cca.2007.02.020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
This work focuses on the main DNA repair pathways, highlighting their role in gastrointestinal carcinogenesis and the role of mitochondrial DNA (mtDNA), mutations being described in several tumor types, including those of the gastrointestinal tract. The mismatch repair (MMR) system is inherently altered in patients with hereditary non-polyposis colorectal cancer, and plays a role in carcinogenesis in a subset of sporadic colorectal, gastric and esophageal cancers. Alterations in homologous recombination (HR) and non-homologous end-joining (NHEJ) also contribute to the development of pancreatic cancer. Gene polymorphisms of some X-ray cross-complementing (XRCCs), cofactor proteins involved in the base excision repair pathway, have been investigated in relation to gastric, colorectal and pancreatic cancer. Yet only one polymorphism, XRCC1 Arg194Trp, appears to be involved in smoking-related cancers and in early onset pancreatic cancer. Although evidence in the literature indicates that mtDNA somatic mutations play a role in gastric and colorectal carcinogenesis, no sound conclusions have yet been drawn regarding this issue in pancreatic cancer, although an mtDNA variant at 16519 is believed to worsen the outcome of pancreatic cancer patients, possibly because it is involved in altering cellular metabolism. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 60 条
[1]   Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause? [J].
Basso, Daniela ;
Greco, Eliana ;
Fogar, Paola ;
Pucci, Piero ;
Flagiello, Angela ;
Baldo, Goretta ;
Giunco, Silvia ;
Valerio, Anna ;
Navaglia, Filippo ;
Zambon, Carlo-Fedenco ;
Falda, Alessandra ;
Pedrazzoli, Sergio ;
Plebani, Mario .
CLINICA CHIMICA ACTA, 2006, 372 (1-2) :120-128
[2]   Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers [J].
Beghelli, S ;
de Manzoni, G ;
Barbi, S ;
Tomezzoli, A ;
Roviello, F ;
Di Gregorio, C ;
Vindigni, C ;
Bortesi, L ;
Parisi, A ;
Saragoni, L ;
Scarpa, A ;
Moore, PS .
SURGERY, 2006, 139 (03) :347-356
[3]   Diabetes and nutrition: The mitochondrial part [J].
Berdanier, CD .
JOURNAL OF NUTRITION, 2001, 131 (02) :344S-353S
[4]   The genetics of colorectal cancer [J].
Calvert, PM ;
Frucht, H .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (07) :603-612
[5]   Mitochondrial defects in cancer [J].
Carew J.S. ;
Huang P. .
Molecular Cancer, 1 (1)
[6]   Mitochondria: Dynamic organelles in disease, aging, and development [J].
Chan, David C. .
CELL, 2006, 125 (07) :1241-1252
[7]   Mitochondrial DNA mutations in human cancer [J].
Chatterjee, A. ;
Mambo, E. ;
Sidransky, D. .
ONCOGENE, 2006, 25 (34) :4663-4674
[8]   Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis [J].
Chen, JJZ ;
Gokden, N ;
Greene, GF ;
Green, B ;
Kadlubar, FF .
CARCINOGENESIS, 2003, 24 (09) :1481-1487
[9]   Mechanisms of human DNA repair: an update [J].
Christmann, M ;
Tomicic, MT ;
Roos, WP ;
Kaina, B .
TOXICOLOGY, 2003, 193 (1-2) :3-34
[10]   High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection [J].
Coller, HA ;
Khrapko, K ;
Bodyak, ND ;
Nekhaeva, E ;
Herrero-Jimenez, P ;
Thilly, WG .
NATURE GENETICS, 2001, 28 (02) :147-150